Scarica l'app Stockscreener
0.3105
2.20%
-0.007
Dopo l'orario di chiusura:
.31
-0.0005
-0.16%
Precedente Chiudi:
$0.3175
Aprire:
$0.3157
Volume 24 ore:
1.70M
Relative Volume:
0.86
Capitalizzazione di mercato:
$7.91M
Reddito:
$486.00K
Utile/perdita netta:
$-28.43M
Rapporto P/E:
-0.1101
EPS:
-2.8189
Flusso di cassa netto:
$-26.75M
1 W Prestazione:
-5.77%
1M Prestazione:
-14.98%
6M Prestazione:
-86.56%
1 anno Prestazione:
-83.57%
Intervallo 1D:
$0.3053
$0.3157
Intervallo di 1 settimana:
$0.3053
$0.3276
Portata 52W:
$0.3053
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Nome
Vyne Therapeutics Inc
Settore
Industria
Telefono
800-775-7936
Indirizzo
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Confronta VYNE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3105 | 8.21M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-11-18 | Iniziato | BTIG Research | Buy |
| 2021-12-06 | Ripresa | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Borsa (VYNE) Ultime notizie
Using economic indicators to assess VYNE Therapeutics Inc. potentialJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
VYNE Therapeutics Inc. stock prediction for this weekPortfolio Value Report & Verified Short-Term Trading Plans - Newser
How institutional ownership impacts VYNE Therapeutics Inc. stockQuarterly Trade Review & High Conviction Buy Zone Alerts - Newser
Using data models to predict VYNE Therapeutics Inc. stock movementJuly 2025 Drop Watch & Stepwise Trade Execution Plans - Newser
VYNE Therapeutics Inc. stock momentum explainedWeekly Stock Summary & Community Driven Trade Alerts - Newser
Is VYNE Therapeutics Inc. stock poised for growthEarnings Performance Report & Risk Managed Trade Strategies - Newser
Institutional scanner results for VYNE Therapeutics Inc.Market Performance Recap & Fast Gaining Stock Strategy Reports - Newser
Is VYNE Therapeutics Inc. a candidate for recovery playProduct Launch & Fast Exit/Entry Strategy Plans - Newser
How to interpret RSI for VYNE Therapeutics Inc. stockJuly 2025 Market Mood & Real-Time Buy Signal Notifications - Newser
Using data filters to optimize entry into VYNE Therapeutics Inc.Long Setup & Fast Gain Swing Trade Alerts - Newser
Is it time to cut losses on VYNE Therapeutics Inc.Weekly Profit Report & Detailed Earnings Play Strategies - Newser
Will VYNE Therapeutics Inc. benefit from rate cutsTrade Entry Summary & Proven Capital Preservation Tips - khodrobank.com
Day Trade: What is VYNE Therapeutics Inc.’s valuation compared to sectorMarket Risk Report & Intraday High Probability Alerts - khodrobank.com
How cyclical is VYNE Therapeutics Inc.’s revenue streamDollar Strength & Real-Time Stock Price Movement Reports - khodrobank.com
VYNE Therapeutics Inc. stock volume spike explainedQuarterly Investment Review & Weekly Hot Stock Watchlists - Newser
How is VYNE Therapeutics Inc. managing supply chain issuesQuarterly Trade Report & Long-Term Capital Growth Strategies - khodrobank.com
Multi asset correlation models including VYNE Therapeutics Inc.Weekly Trend Summary & Community Shared Stock Ideas - Newser
VYNE Therapeutics Inc. Rebounds From Oversold Zone — Now What getLinesFromResByArray error: size == 0 - thegnnews.com
Will VYNE Therapeutics Inc. stock recover after recent dropQuarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Is VYNE Therapeutics Inc. stock entering bullish territoryPortfolio Gains Report & Verified Short-Term Plans - Newser
Sector ETF performance correlation with VYNE Therapeutics Inc.July 2025 Gainers & Stepwise Trade Signal Implementation - Newser
What to do if you’re stuck in VYNE Therapeutics Inc.Market Performance Report & Technical Pattern Recognition Alerts - Newser
Will VYNE Therapeutics Inc. price bounce be sustainableBond Market & Safe Capital Growth Tips - Newser
Is this a good reentry point in VYNE Therapeutics Inc.Quarterly Growth Report & Stock Timing and Entry Methods - Newser
What MACD and RSI say about VYNE Therapeutics Inc.Quarterly Market Summary & Verified Momentum Stock Alerts - Newser
Chart based exit strategy for VYNE Therapeutics Inc.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Vyne Therapeutics Inc Azioni (VYNE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):